A randomized, open-label, single-dose parallel group study of the pharmacokinetic profile, safety, and tolerability of 25- and 50-mg desvenlafaxine sustained release (DVS SR) in healthy subjects

Trial Profile

A randomized, open-label, single-dose parallel group study of the pharmacokinetic profile, safety, and tolerability of 25- and 50-mg desvenlafaxine sustained release (DVS SR) in healthy subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Apr 2007

At a glance

  • Drugs Desvenlafaxine (Primary)
  • Indications Major depressive disorder; Vasomotor symptoms
  • Focus Adverse reactions
  • Sponsors Wyeth
  • Most Recent Events

    • 04 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top